These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6331515)

  • 21. Tumor necrosis factor up-regulates expression of low-density lipoprotein receptors on HepG2 cells.
    Liao W; Florén CH
    Hepatology; 1993 May; 17(5):898-907. PubMed ID: 8387950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low- and high-density lipoprotein metabolism in HepG2 cells expressing various levels of apolipoprotein E.
    Charpentier D; Tremblay C; Rassart E; Rhainds D; Auger A; Milne RW; Brissette L
    Biochemistry; 2000 Dec; 39(51):16084-91. PubMed ID: 11123936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of hepatic receptor-dependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starch-casein diet.
    Chao YS; Kroon PA; Yamin TT; Thompson GM; Alberts AW
    Biochim Biophys Acta; 1983 Nov; 754(2):134-41. PubMed ID: 6317039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low density lipoprotein binding, internalization, and degradation in human adipose cells.
    Angel A; D'Costa MA; Yuen R
    Can J Biochem; 1979 Jun; 57(6):578-87. PubMed ID: 224983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of rat and human lipoproteins by cultured rat ovary granulosa cells.
    Schreiber JR; Nakamura K; Weinstein DB
    Endocrinology; 1982 Jan; 110(1):55-63. PubMed ID: 7053994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and degradation of lipoproteins by human trophoblastic cells in primary culture.
    Winkel CA; Gilmore J; MacDonald PC; Simpson ER
    Endocrinology; 1980 Dec; 107(6):1892-8. PubMed ID: 7428697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine-induced interference with degradation of serum lipoproteins in rat liver, studied in vivo and in vitro.
    Stein Y; Ebin V; Bar-On H; Stein O
    Biochim Biophys Acta; 1977 Feb; 486(2):286-97. PubMed ID: 189819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the uptake of high-density lipoprotein-originated cholesteryl ester by HepG2 cells: role of low-density lipoprotein and plasma lipid transfer protein.
    Francis GA; Ko KW; Hara H; Yokoyama S
    Biochim Biophys Acta; 1991 Jul; 1084(2):159-66. PubMed ID: 1649639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2.
    Maziere C; Maziere JC; Salmon S; Auclair M; Mora L; Moreau M; Polonovski J
    Biochem Biophys Res Commun; 1988 Oct; 156(1):424-31. PubMed ID: 2845980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
    Barnard GF; Erickson SK; Cooper AD
    J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
    Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
    J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells.
    Quaschning T; Königer M; Krämer-Guth A; Greiber S; Pavenstädt H; Nauck M; Schollmeyer P; Wanner C
    Nephrol Dial Transplant; 1997 Dec; 12(12):2528-36. PubMed ID: 9430847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):837-44. PubMed ID: 8382053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the regulation of cholesterol metabolism by low- and high-density lipoproteins in HepG2 cells.
    Ranganathan S; Kottke BA
    Hepatology; 1989 Apr; 9(4):547-51. PubMed ID: 2925159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding, degradation, and utilization of plasma high density and low density lipoproteins for progesterone production in cultured rat luteal cells.
    Rajendran KG; Hwang J; Menon KM
    Endocrinology; 1983 May; 112(5):1746-53. PubMed ID: 6299707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptors for homologous plasma lipoproteins on a rat hepatoma cell line.
    Tamai T; Patsch W; Lock D; Schonfeld G
    J Lipid Res; 1983 Dec; 24(12):1568-77. PubMed ID: 6321620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein C-III can specifically bind to hepatic plasma membranes.
    Fang DZ; Liu BW
    Mol Cell Biochem; 2000 Apr; 207(1-2):57-64. PubMed ID: 10888227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between composition and cellular uptake of lipoproteins from normal and hyperlipemic swine.
    Shireman RB; Coffey MT
    J Nutr; 1984 Dec; 114(12):2373-82. PubMed ID: 6502280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein C-I reduces cholesteryl esters selective uptake from LDL and HDL by binding to HepG2 cells and lipoproteins.
    Krasteva V; Brodeur MR; Tremblay FL; Falstrault L; Brissette L
    Biochim Biophys Acta; 2010 Jan; 1801(1):42-8. PubMed ID: 19761869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
    Bochkov VN; Tkachuk VA; Kuzmenko YS; Borisova YL; Bühler FR; Resink TJ
    Mol Pharmacol; 1994 Feb; 45(2):262-70. PubMed ID: 8114675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.